Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy
This study aims to evaluate the effectiveness, tolerability, and safety of using cooling therapy and pressure (cryocompression) to reduce peripheral neuropathy, a condition affecting the nerves supplying the arms and legs (limbs) resulting in possible numbness, pain, and/or loss of motor function, that may occur as a result of taxane-based chemotherapy. The name of the device used in this research study is: -Paxman Limb Cryocompression System (PLCS)
• Adults \> 18 years of age
• Gynecologic or breast malignancy
• Starting 1st cycle of treatment with chemotherapy regimens:
‣ Weekly paclitaxel x 12 or weekly paclitaxel/carboplatin x 12 (Breast Oncology)
⁃ Q3 weeks paclitaxel/carboplatin X 6-8 (GYN)
• Receiving treatment on the main campus of DFCI (these patients are currently seen on Yawkey 9 and 10 and at Chestnut Hill)
• Able to complete questionnaires in English or Spanish